SequelSEC

CDT Equity Inc. CDT

Pharmaceutical Preparations · CIK 0001896212 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$36.76M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

CDT Equity Inc. (CDT) reported net income of -$39.22M for the fiscal year ended 2025-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from CDT Equity Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

CDT Equity Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
RevenueUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating income-$36.76M-$15.42M-$5.26M-$3.16M
Net income-$39.22M-$17.80M-$535.00K-$4.89M
Research & development$5.05M$3.38M$90.00K$37.00K
Weighted-average diluted sharesUnavailableUnavailableUnavailableshares 37.45M
Pretax income-$39.22M-$17.80M-$536.00K$773.50K
Income tax expenseUnavailableUnavailableUnavailable$374.86K
Diluted EPS$-1,177.89$-61,598.62$-8.92$-0.13
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable
General & administrative$31.70M$12.04M$5.17M$3.05M
Selling & marketingUnavailableUnavailableUnavailableUnavailable

Balance

CDT Equity Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Cash & equivalents$1.51M$554.00K$4.23M$345.78K
Total assets$5.65M$4.19M$7.22M$5.00K
Current assets$4.38M$2.72M$5.73M$646.64K
Total liabilities$12.82M$10.99M$7.68M$10.09M
Current liabilities$12.82M$10.74M$1.80M$4.18M
Total equity incl. NCI-$7.17M-$6.79M-$457.00K-$10.09M
Temporary (mezzanine) equityUnavailableUnavailableUnavailable$136.77M
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.91M$1.43M$215.00KUnavailable

Cash flow

CDT Equity Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Operating cash flow-$15.56M-$9.68M-$7.72M-$2.27M
Capital expendituresUnavailable$51.00KUnavailableUnavailable
Investing cash flow-$808.00K-$43.00K$725.00K-$183.00K
Financing cash flow$17.42M$6.07M$10.93M$2.45M
Net change in cash$955.00K-$3.67M$4.23M$297.22K
Stock-based compensation$2.18M$1.63M$199.00KUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchases$106.00KUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailable

Derived

CDT Equity Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratio0.34x0.25x3.18xUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable48.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CDT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-07-15View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q/A · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2022-12-31

Difference 136771183 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.